We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.5B
AUM Growth
+$941M
Cap. Flow
+$1.2B
Cap. Flow %
8.27%
Top 10 Hldgs %
50.76%
Holding
909
New
194
Increased
274
Reduced
256
Closed
181

Top Buys

Rank Stock Value
1
RMP
Rice Midstream Partners LP
RMP
+$126M
2
ETP
Energy Transfer Partners L.p.
ETP
+$90.9M
3
EPD icon
Enterprise Products Partners
EPD
+$88.4M
4
PAA icon
Plains All American Pipeline
PAA
+$78.1M
5
WES
Western Gas Partners Lp
WES
+$63.9M

Top Sells

Rank Stock Value
1
PBI icon
Pitney Bowes
PBI
+$36.3M
2
FTR
Frontier Communications Corp.
FTR
+$34.8M
3
BN icon
Brookfield
BN
+$32.6M
4
RGLD icon
Royal Gold
RGLD
+$15.5M
5
DHR icon
Danaher
DHR
+$12.5M

Sector Composition

Rank Sector Weight
1 Energy 65.56%
2 Materials 2.69%
3 Financials 2.68%
4 Healthcare 2.39%
5 Industrials 2.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
151
Alnylam Pharmaceuticals
ALNY
$36.3B
$3.79M 0.03%
73,998
-8,470
-10% -$391K
KITE
152
DELISTED
Kite Pharma, Inc.
KITE
$3.7M 0.03%
47,173
-757
-2% -$46.8K
ACAD icon
153
Acadia Pharmaceuticals
ACAD
$4.25B
$3.58M 0.02%
104,195
-12,196
-10% -$431K
OGE icon
154
OGE Energy
OGE
$10.3B
$3.43M 0.02%
98,102
+16,737
+21% +$583K
LKFT
155
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$3.42M 0.02%
39,668
-4,641
-10% -$334K
NBIX icon
156
Neurocrine Biosciences
NBIX
$17.7B
$3.25M 0.02%
74,944
-8,538
-10% -$366K
BLUE
157
DELISTED
bluebird bio
BLUE
$3.19M 0.02%
2,713
-55
-2% -$56.1K
AKRX
158
DELISTED
Akorn Inc
AKRX
$3.1M 0.02%
128,530
-6,980
-5% -$152K
MINT icon
159
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$3.02M 0.02%
29,672
– –
AROC icon
160
Archrock
AROC
$6.33B
$2.84M 0.02%
228,818
-7,198
-3% -$101K
GWPH
161
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.63M 0.02%
21,769
-1,973
-8% -$242K
EXK
162
Endeavour Silver
EXK
$2.32B
$2.56M 0.02%
804,682
-21,057
-3% -$82.4K
PSA icon
163
Public Storage
PSA
$60.2B
$2.52M 0.02%
12,696
-1,608
-11% -$356K
EQIX icon
164
Equinix
EQIX
$107B
$2.44M 0.02%
6,605
-180
-3% -$68.4K
RARE icon
165
Ultragenyx Pharmaceutical
RARE
$2.65B
$2.43M 0.02%
35,898
-3,366
-9% -$257K
ICPT
166
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.41M 0.02%
21,342
-2,500
-10% -$292K
SPG icon
167
Simon Property Group
SPG
$74.5B
$2.4M 0.02%
15,390
-1,994
-11% -$356K
AAPL icon
168
Apple
AAPL
$4.89T
$2.36M 0.02%
65,724
+23,396
+55% +$770K
SAGE
169
DELISTED
Sage Therapeutics
SAGE
$2.27M 0.02%
31,975
-3,741
-10% -$219K
ENDP
170
DELISTED
Endo International plc
ENDP
$2.26M 0.02%
204,155
-10,027
-5% -$125K
NGD
171
DELISTED
New Gold Inc
NGD
$2.26M 0.02%
757,290
-1,512,650
-67% -$4.89M
PLD icon
172
Prologis
PLD
$138B
$2.13M 0.01%
45,092
-5,287
-10% -$269K
AGIO icon
173
Agios Pharmaceuticals
AGIO
$2.16B
$2.12M 0.01%
36,335
-4,042
-10% -$194K
HZNP
174
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.03M 0.01%
138,731
-16,235
-10% -$263K
JUNO
175
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.02M 0.01%
91,082
-10,659
-10% -$229K
5 6
7
8 9

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, ALPS Advisors held 909 positions worth $14.5B, up 6.9% from $13.6B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

ALPS Advisors deployed $1.2B of net new capital in Q1 2017, opening 194 new positions and adding to 274 existing holdings. Its largest new stake was Newmont: 609,201 shares worth $20.1M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 67% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was Royal Gold, an estimated $15.5M trimmed.

  • ALPS Advisors's largest Q1 2017 buy was Newmont: 609,201 shares worth $20.1M.
  • ALPS Advisors added most to Rice Midstream Partners LP in Q1 2017, an estimated $126M increase.
  • ALPS Advisors's biggest Q1 2017 reduction was Royal Gold, cutting an estimated $15.5M.
  • ALPS Advisors fully exited Pitney Bowes in Q1 2017, selling an estimated $36.3M.
  • ALPS Advisors's ten largest holdings make up 51% of its $14.5B portfolio in Q1 2017.
  • ALPS Advisors opened 194 new positions and closed 181 in Q1 2017.
  • ALPS Advisors's portfolio value rose 6.9% quarter-over-quarter to $14.5B.

Based on ALPS Advisors's 13F filing for Q1 2017, filed 12 May 2017.